Cambridge Investment Research Advisors’s NetEase NTES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$655K Buy
5,109
+128
+3% +$15.1K ﹤0.01% 2710
2026
Q1
$558K Buy
4,981
+271
+6% +$33.6K ﹤0.01% 2690
2025
Q4
$648K Buy
4,710
+136
+3% +$19.3K ﹤0.01% 2481
2025
Q3
$695K Buy
4,574
+593
+15% +$81.6K ﹤0.01% 2359
2025
Q2
$536K Sell
3,981
-282
-7% -$32.4K ﹤0.01% 2481
2025
Q1
$439K Sell
4,263
-539
-11% -$54.2K ﹤0.01% 2557
2024
Q4
$428K Sell
4,802
-97
-2% -$8.5K ﹤0.01% 2556
2024
Q3
$458K Buy
4,899
+786
+19% +$68.6K ﹤0.01% 2480
2024
Q2
$393K Sell
4,113
-306
-7% -$29.1K ﹤0.01% 2484
2024
Q1
$457K Sell
4,419
-674
-13% -$68.9K ﹤0.01% 2350
2023
Q4
$474K Sell
5,093
-1,374
-21% -$146K ﹤0.01% 2223
2023
Q3
$648K Buy
6,467
+752
+13% +$77.1K ﹤0.01% 1877
2023
Q2
$553K Buy
5,715
+1,730
+43% +$156K ﹤0.01% 2048
2023
Q1
$352K Buy
3,985
+281
+8% +$24.2K ﹤0.01% 2345
2022
Q4
$269K Sell
3,704
-406
-10% -$27.6K ﹤0.01% 2521
2022
Q3
$311K Buy
4,110
+172
+4% +$15.1K ﹤0.01% 2334
2022
Q2
$368K Sell
3,938
-768
-16% -$73.1K ﹤0.01% 2194
2022
Q1
$422K Sell
4,706
-1,948
-29% -$185K ﹤0.01% 2241
2021
Q4
$677K Sell
6,654
-5,398
-45% -$548K ﹤0.01% 1860
2021
Q3
$1.03M Sell
12,052
-11,906
-50% -$1.12M 0.01% 1490
2021
Q2
$2.76M Buy
23,958
+2,367
+11% +$261K 0.01% 941
2021
Q1
$2.23M Buy
21,591
+6,938
+47% +$785K 0.01% 950
2020
Q4
$1.4M Sell
14,653
-1,317
-8% -$118K 0.01% 1113
2020
Q3
$1.45M Buy
15,970
+5,080
+47% +$478K 0.01% 977
2020
Q2
$935K Sell
10,890
-15
-0.1% -$1.13K 0.01% 1156
2020
Q1
$700K Buy
10,905
+3,205
+42% +$211K 0.01% 1169
2019
Q4
$472K Sell
7,700
-1,235
-14% -$72.4K ﹤0.01% 1621
2019
Q3
$476K Buy
8,935
+1,590
+22% +$80.9K ﹤0.01% 1532
2019
Q2
$376K Sell
7,345
-625
-8% -$33.2K ﹤0.01% 1615
2019
Q1
$385K Buy
7,970
+1,610
+25% +$76.6K ﹤0.01% 1651
2018
Q4
$299K Sell
6,360
-21,805
-77% -$984K ﹤0.01% 1673
2018
Q3
$1.29M Buy
28,165
+19,650
+231% +$904K 0.01% 889
2018
Q2
$430K Sell
8,515
-245
-3% -$12.5K ﹤0.01% 1483
2018
Q1
$491K Sell
8,760
-1,440
-14% -$90.4K 0.01% 1364
2017
Q4
$704K Sell
10,200
-17,695
-63% -$1.11M 0.01% 1105
2017
Q3
$1.47M Buy
27,895
+19,660
+239% +$1.13M 0.02% 651
2017
Q2
$495K Buy
8,235
+785
+11% +$45K 0.01% 1212
2017
Q1
$423K Buy
7,450
+1,230
+20% +$66.2K 0.01% 1161
2016
Q4
$268K Buy
6,220
+150
+2% +$7.16K 0.01% 1342
2016
Q3
$292K Sell
6,070
-11,375
-65% -$484K 0.01% 1312
2016
Q2
$674K Buy
+17,445
New +$543K 0.01% 795
2015
Q3
Sell
-15,865
Closed -$460K 1562
2015
Q2
$460K Sell
15,865
-3,250
-17% -$86.8K 0.01% 855
2015
Q1
$403K Sell
19,115
-13,540
-41% -$286K 0.01% 909
2014
Q4
$648K Sell
32,655
-1,500
-4% -$28.7K 0.02% 649
2014
Q3
$585K Buy
+34,155
New +$580K 0.02% 735

Other funds holding NTES

Cambridge Investment Research Advisors's NTES Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its NetEase (NTES) stake by 2.6% in Q2 2026, buying an estimated $15.1K and bringing the position to 5,109 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

Cambridge Investment Research Advisors first reported a position in NTES in Q3 2014 and has held it in 45 quarters since. The position peaked at $2.76M in Q2 2021. 458 funds tracked by Wall St. Rank hold NTES as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,109 shares of NetEase worth $655K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 128 NetEase shares in Q2 2026, an estimated $15.1K.
  • NetEase made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2710 holding.
  • Cambridge Investment Research Advisors first reported a position in NetEase in Q3 2014 and has held it in 45 quarters since.
  • Cambridge Investment Research Advisors's NetEase position peaked at $2.76M in Q2 2021.
  • 458 funds tracked by Wall St. Rank held NetEase as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.